Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Eleanor Avril"'
Autor:
Petr Makhov, Igor Bychkov, Bulat Faezov, Alexander Deneka, Alexander Kudinov, Emmanuelle Nicolas, Rohan Brebion, Eleanor Avril, Kathy Q. Cai, Leonid V. Kharin, Mark Voloshin, Elena Frantsiyants, Nikolay Karnaukhov, Oleg I. Kit, Iuliia Topchu, Rushaniya Fazliyeva, Anna S. Nikonova, Ilya G. Serebriiskii, Hossein Borghaei, Martin Edelman, Essel Dulaimi, Erica A. Golemis, Yanis Boumber
Publikováno v:
Oncogenesis, Vol 10, Iss 3, Pp 1-14 (2021)
Abstract Non-small cell lung cancer (NSCLC) has limited treatment options. Expression of the RNA-binding protein (RBP) Musashi-2 (MSI2) is elevated in a subset of non-small cell lung cancer (NSCLC) tumors upon progression, and drives NSCLC metastasis
Externí odkaz:
https://doaj.org/article/2ede848ef5274440b27190aa152d7cbe
Autor:
Martin J. Edelman, Oleg I. Kit, Elena M. Frantsiyants, Rohan Brebion, Eleanor Avril, Kathy Q. Cai, Bulat Faezov, Iuliia Topchu, Rushaniya Fazliyeva, Ilya G. Serebriiskii, Emmanuelle Nicolas, Leonid V. Kharin, Petr Makhov, Yanis Boumber, Erica A. Golemis, Alexander E. Kudinov, Hossein Borghaei, Igor Bychkov, Alexander Y. Deneka, Anna S. Nikonova, Nikolay S. Karnaukhov, Essel Dulaimi, Mark Voloshin
Publikováno v:
Oncogenesis, Vol 10, Iss 3, Pp 1-14 (2021)
Oncogenesis
Oncogenesis
Non-small cell lung cancer (NSCLC) has limited treatment options. Expression of the RNA-binding protein (RBP) Musashi-2 (MSI2) is elevated in a subset of non-small cell lung cancer (NSCLC) tumors upon progression, and drives NSCLC metastasis. We eval
Autor:
Hossein Borghaei, Kathy Q. Cai, Vladimir Khazak, Mark A. Hitrik, Peter Makhov, Anna S. Nikonova, Rohan Brebion, Ilya G. Serebriiskii, Yanis Boumber, Brian L. Egleston, Eleanor Avril, Erica A. Golemis, Emmanuelle Nicolas, Alexander E. Kudinov, Alexander Y. Deneka
Publikováno v:
Cancer Research. 78:4452-4452
Musashi-2 (MSI2) is an RNA-binding protein that regulates mRNA translation. We recently established that MSI2 is elevated in a subset of non-small cell lung cancer (NSCLC) tumors upon progression and drives NSCLC metastasis, in part based on activity